Amgen Inc.
TREATMENT OF ASTHMA WITH ANTI-TSLP ANTIBODY
Last updated:
Abstract:
The present disclosure, relates, in general, to methods of treating asthma, including severe asthma and eosinophilic asthma, using an antibody specific for thymic stromal lymphopoietin (TSLP).
Status:
Application
Type:
Utility
Filling date:
9 Nov 2020
Issue date:
25 Feb 2021